TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTDPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Jun 3 to Jun 18 ▼ 4 days of insider sells: $4.7M by 3 insiders, avg $33.83
- Jun 30 ▲ 4 funds open new positions (13F)
- Aug 3 to Aug 5 ▼ 2 days of insider sells: $1.3M by 3 insiders, avg $34.88
- Aug 17 to Aug 21 ▼ 2 days of insider sells: $1.1M by 3 insiders, avg $36.93
- Sep 2 to Sep 4 2 court rulings: LUE v. TEVA PHARMACEUTICALS USA, INC. et al; Edgar et al v. Teva Pharmaceuticals Industries, Ltd. et al
- Sep 15 ▼ Short interest jumps 11467.5% to 31.48M
- Sep 18 ▼ 2 insiders sell $14.6M at $39.05
- Nov 2 HC Wainwright & Co. initiates
- Nov 3 ▲ Teva reported Q3 2026 non-GAAP diluted EPS of $0.86, beating the $0.…
- Nov 3 FDA: Teva and Samsung Bioepis Announce Agreement to Commerciali…
- Nov 4 to Nov 12 ▼ 6 days of insider sells: $18.2M by 5 insiders, avg $42.47
- Nov 4 Trial readout: Results Pending: Fp/ABS (Phase 3), completed 9d ago
Signal stack
Where each data set points today.
- InsidersBEARISH
14 insiders sold $40.0M.
- InstitutionsBULLISH
Q2 2026: 48 added (4 new), 25 trimmed or exited. Largest new: Meitav Investment House $336.9M, Adage Capital Partners Gp, L.L.C $80.0M.
- AnalystsBULLISH
6 of 7 rate it Buy or better. Median target $49.50 (+16%).
- Short sellersSTEADY
Short interest −1.2% to 27.74M shares. 5.3 days to cover, ≈2.4% of shares.
- TrendUPTREND
6% above its 50-day average. New closing high $44.50 on Nov 13.
- SocialQUIET
No Reddit mentions this week. Last mention Nov 4.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| Capital World Investors | ADD | $424.7M |
| MEITAV INVESTMENT HOUSE LTD | NEW | $336.9M |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | DOUBLED | $223.4M |
| GOLDMAN SACHS GROUP INC | ADD | $207.7M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | DOUBLED | $129.8M |
| MILLENNIUM MANAGEMENT LLC | ADD | $110.6M |
| Assenagon Asset Management S.A. | DOUBLED | $103.5M |
| CITIGROUP INC | DOUBLED | $85.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
7 analystsPrice is inside the target range. Median implies +16%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 12, 2026 | Piper Sandler MAINTAIN | Overweight |
| Nov 5, 2026 | Leerink Partners MAINTAIN | Outperform |
| Nov 4, 2026 | TD Cowen MAINTAIN | Buy |
| Nov 4, 2026 | HC Wainwright & Co. MAINTAIN | Buy |
| Nov 2, 2026 | HC Wainwright & Co. INITIATE | Buy |
| Oct 15, 2026 | Barclays MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Sabag Mark See "Remarks" Nov 12, 2026 | SELL | $2.0M |
Sabag Mark See "Remarks" Nov 12, 2026 | EXERCISE | $1.6M |
Daniell Richard EVP, Europe Commercial Nov 11, 2026 | SELL | $856.2K |
Daniell Richard EVP, Europe Commercial Nov 11, 2026 | EXERCISE | $694.1K |
BRAILER DAVID J Director Nov 10, 2026 | AWARD | 3,326 sh |
Bergwerk Dov Interim Chief Legal Officer Nov 10, 2026 | AWARD | 9,433 sh |
Francis Richard D President and CEO Nov 10, 2026 | SELL | $10.6M |
Weiss Amir Chief Accounting Officer Nov 9, 2026 | EXERCISE | $269.1K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
45 filings · 16 press releases · 7 bullish · 3 bearish · 3 mixed · 32 neutral- NEUTRAL SC 13G/ANov 16, 2026
Phoenix Financial Ltd. filed an amended Schedule 13G disclosing a 4.85% passive stake in Teva (56,550,148.77 ordinary shares) as of November 4, 2026, down from its prior stake. The filing confirms a passive intent and no change of control influence.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL 3Nov 12, 2026
David J. Brailer filed a Form 3 initial statement of beneficial ownership upon becoming a…
Monitor future Form 4 filings for any insider transactions by Brailer, which would signal his view of the stock. No immediate trading signal from this initial filing.
- NEUTRAL 144Nov 12, 2026
Mark Sabag, EVP of International Markets Commercial at Teva, filed a Form 144 notice of intent to…
This is a routine insider sale tied to option exercise and compensation. The dollar amount is immaterial relative to Teva's market cap. No further action warranted unless subsequent Form 4 filings…
- NEUTRAL 144Nov 12, 2026
Richard Daniell, Executive VP European Commercial at Teva, filed a Form 144 notice of intent to…
The sale is small and routine for an executive exercising options; no material signal for the stock. Monitor for any larger insider sales or changes in executive holdings in future Form 4 filings.
All TEVA filing & press-release reports (61)
- SC 13G/A reportNov 16, 2026
- 3 reportNov 12, 2026
- 144 reportNov 12, 2026
- 144 reportNov 12, 2026
- 144 reportNov 10, 2026
- SC 13G/A reportNov 10, 2026
- 144 reportNov 9, 2026
- CLUSTER reportNov 6, 2026
- CLUSTER reportNov 6, 2026
- 144 reportNov 5, 2026
- 144 reportNov 4, 2026
- 8-K reportNov 3, 2026
- PRESS-RELEASE reportNov 3, 2026
- PRESS-RELEASE reportNov 3, 2026
- PRESS-RELEASE reportNov 2, 2026
- SC 13G/A reportNov 2, 2026
- 8-K reportOct 29, 2026
- PRESS-RELEASE reportOct 27, 2026
- INST-CLUSTER reportOct 15, 2026
- 3 reportOct 8, 2026
- PRESS-RELEASE reportOct 2, 2026
- PRESS-RELEASE reportOct 2, 2026
- PRESS-RELEASE reportSep 30, 2026
- PRESS-RELEASE reportSep 28, 2026
- PRESS-RELEASE reportSep 23, 2026
- PRESS-RELEASE reportSep 23, 2026
- CLUSTER reportSep 22, 2026
- PRESS-RELEASE reportSep 18, 2026
- PRESS-RELEASE reportSep 18, 2026
- PRESS-RELEASE reportSep 10, 2026
- 424B5 reportSep 8, 2026
- COURT-RULING reportSep 4, 2026
- COURT-RULING reportSep 2, 2026
- PRESS-RELEASE reportAug 28, 2026
- COURT-RULING reportAug 25, 2026
- CLUSTER reportAug 25, 2026
- CLUSTER reportAug 10, 2026
- CLUSTER reportAug 5, 2026
- COURT-RULING reportJul 31, 2026
- 8-K reportJul 29, 2026
- COURT-RULING reportJul 23, 2026
- INST-CLUSTER reportJul 20, 2026
- COURT-RULING reportJul 15, 2026
- COURT-RULING reportJul 13, 2026
- COURT-RULING reportApr 13, 2026
- COURT-RULING reportApr 13, 2026
- CLUSTER reportJun 16, 2026
- PRESS-RELEASE reportJun 10, 2026
- CLUSTER reportJun 8, 2026
- PRESS-RELEASE reportJun 5, 2026
- CLUSTER reportMay 18, 2026
- PRESS-RELEASE reportMay 18, 2026
- PRESS-RELEASE reportApr 29, 2026
- PRESS-RELEASE reportApr 29, 2026
- COURT-RULING reportApr 16, 2026
- PRESS-RELEASE reportMar 19, 2026
- CLUSTER reportFeb 26, 2026
- CLUSTER reportFeb 26, 2026
- CLUSTER reportFeb 26, 2026
- CLUSTER reportFeb 26, 2026
- INST-CLUSTER reportFeb 28, 2026